Lawrence Rasouliyan

2.2k citations

47 papers · 1.5k indexed · h-index 19

Pulmonary and Respiratory Medicine top 2%
- Cystic Fibrosis Research Advances 12
- Respiratory and Cough-Related Research 8
Physiology top 5%
- Asthma and respiratory diseases 9
Speech and Hearing top 5%
Immunology and Allergy top 10%
Emergency Medical Services top 5%
Immunology
- Psoriasis: Treatment and Pathogenesis 11
Rheumatology
- Spondyloarthritis Studies and Treatments 9
- Rheumatoid Arthritis Research and Therapies 6
Hematology
- Autoimmune and Inflammatory Disorders Research 7
Epidemiology
- Pneumonia and Respiratory Infections 5

Co-authors: David J. Pasta Jeffrey S. Wagener Bradley E. Chipps Michael W. Konstan Tmirah Haselkorn Wayne J. Morgan Ashley Yegin Alexandra L. Quittner
Cited by: Pulmonary and Respiratory Medicine Physiology Speech and Hearing
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Lawrence Rasouliyan

42 papers receiving 1.4k citations

Peers

Countries citing papers authored by Lawrence Rasouliyan

Since Specialization

Citations

This map shows the geographic impact of Lawrence Rasouliyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Rasouliyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Rasouliyan more than expected).

Fields of papers citing papers by Lawrence Rasouliyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Rasouliyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Rasouliyan. The network helps show where Lawrence Rasouliyan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lawrence Rasouliyan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lawrence Rasouliyan Line = papers co-authored together Lawrence Rasouliyan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	54043 Guselkumab for Treatment of Plaque Psoriasis: Persistence and Switching in Real-World Clinical Practices in the US Lawrence Rasouliyan,Timothy Fitzgerald,Rachel E. Teneralli,Jing Zhao,David T. Wu	2024	0
2	RWD98 Reasons for Biologic Treatment Alteration in Inflammatory Bowel Disease: Insights from Unstructured Clinical Notes Derived from Large Language Models Yan Wang,Lawrence Rasouliyan,Vikas Kumar	2024	1
3	HPR113 Social Determinants of Health and Use of Glucagon-like Peptide-1 Receptor Agonists in the Pediatric Population David F. Black,Angelina Mummert,S. Long,Lawrence Rasouliyan	2024	1
4	Cardiovascular comorbidities in atopic dermatitis: Potential implications for the use of Janus kinase inhibitors J. Mark Jackson,A. Althoff,Lawrence Rasouliyan,Stacey R. Long,Carla L. Zema	2023	1
5	PIT1 Negative Pressure Wound Therapy for Pressure Ulcer: Effect on Outcomes and Utilization Using Real-World DATA Vvv Amruth Kumar,Lawrence Rasouliyan,Shenfei Long,Rao B	2021	1
6	Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies Laura C. Coates,Johan K. Wallman,Dennis McGonagle,Georg Schett,Iain B. McInnes,Philip J. Mease,Lawrence Rasouliyan,Erhard Quebe‐Fehling,Darren L. Asquith,Andreas E. R. Fasth,Luminita Pricop,Corine Gaillez	2019	13
7	Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study (unknown),Laura C. Coates,Dafna D. Gladman,Peter Nash,Oliver FitzGerald,Arthur Kavanaugh,Tore K Kvien,Laure Gossec,Vibeke Strand,Lawrence Rasouliyan,Luminita Pricop,Kevin Ding,SM Jugl,Corine Gaillez	2018	27
8	AB0772 Secukinumab provides sustained improvement in function, quality of life and fatigue over 2 years in patients who achieved low disease activity related to psoriatic arthritis disease activity score (PASDAS) Laura C. Coates,Tore K Kvien,Peter Nash,Laure Gossec,Vibeke Strand,Luminita Pricop,Lawrence Rasouliyan,Kevin Ding,SM Jugl,Corine Gaillez	2017	2
9	Secukinumab Provides Sustained Minimal Disease Activity (MDA) and Remission Related to Disease Activity Index for Psoriatic Arthritis (DAPSA): 2-Year Results from a Phase 3 Study Laura C. Coates,Peter Nash,Tore K Kvien,Laure Gossec,Philip J. Mease,Lawrence Rasouliyan,Luminita Pricop,Corine Gaillez,Josef S Smolen	2017	1
10	The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis Paul Wicks,Lawrence Rasouliyan,Bo Katic,Beenish Nafees,Emuella Flood,Rahul Sasané	2016	28
11	Interim Results From INJECT: INvestigation of JETREA in Patients With Confirmed Vitreomacular Traction Peter Stalmans,Franklin Masin,Claudio Spera,Severine Durier,Lawrence Rasouliyan	2015	2
12	Impact of Asthma Exacerbations and Asthma Triggers on Asthma-related Quality of Life in Patients with Severe or Difficult-to-Treat Asthma Allan T. Luskin,Bradley E. Chipps,Lawrence Rasouliyan,Dave P. Miller,Tmirah Haselkorn,Alejandro Dorenbaum	2014	78
13	PND46 Longitudinal Assessment of Health-Related Quality of Life in an Observational Cohort of Patients With Cystic Fibrosis G. Sawicki,Lawrence Rasouliyan,Ann McMullen,Jeffrey S. Wagener,Susanna A. McColley,D.J. Pasta,Alexandra L. Quittner	2012	1
14	Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations Robert S. Zeiger,Ashley Yegin,F. Estelle R. Simons,Tmirah Haselkorn,Lawrence Rasouliyan,Stanley J. Szefler,Bradley E. Chipps	2012	40
15	Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis Clement L. Ren,Michael W. Konstan,Ashley Yegin,Lawrence Rasouliyan,Benjamin Trzaskoma,Wayne J. Morgan,Warren E. Regelmann	2012	45
16	Longitudinal assessment of health‐related quality of life in an observational cohort of patients with cystic fibrosis Gregory S. Sawicki,Lawrence Rasouliyan,Ann McMullen,Jeffrey S. Wagener,Susanna A. McColley,David J. Pasta,Alexandra L. Quittner	2010	81
17	Patient-Reported Outcomes among Omalizumab and Salmeterol/Fluticasone Combination Therapy Patients Dave P. Miller,Gladys Tom,Lawrence Rasouliyan,Bradley E. Chipps	2009	5
18	Impact of Socioeconomic Status, Race, and Ethnicity on Quality of Life in Patients With Cystic Fibrosis in the United States Alexandra L. Quittner,Michael S. Schechter,Lawrence Rasouliyan,Tmirah Haselkorn,David J. Pasta,Jeffrey S. Wagener	2009	97
19	The response to combination therapy treatment regimens in severe/difficult-to-treat asthma Jonathan D. Campbell,Larry Borish,Tmirah Haselkorn,Lawrence Rasouliyan,J. H. Lee,Sally E. Wenzel,SD Sullivan	2008	13
20	Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005 Donald R. VanDevanter,Lawrence Rasouliyan,Thomas M. Murphy,Wayne J. Morgan,Clement L. Ren,Michael W. Konstan,Jeffrey S. Wagener	2008	18

About Lawrence Rasouliyan

Lawrence Rasouliyan is a scholar working on Rheumatology, Health Informatics and Hematology, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (12 papers), Psoriasis: Treatment and Pathogenesis (11 papers), Spondyloarthritis Studies and Treatments (9 papers), Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (8 papers), Autoimmune and Inflammatory Disorders Research (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Pneumonia and Respiratory Infections (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.1k citations), Physiology (488 citations) and Speech and Hearing (102 citations). Lawrence Rasouliyan has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include David J. Pasta, Jeffrey S. Wagener, Bradley E. Chipps, Michael W. Konstan, Tmirah Haselkorn, Wayne J. Morgan, Ashley Yegin, Alexandra L. Quittner, Gregory S. Sawicki and Donald R. VanDevanter.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact